Intracranial Hemorrhage in the TST Trial
暂无分享,去创建一个
E. Vicaut | P. Amarenco | N. Nighoghossian | P. Steg | E. Bruckert | M. Giroud | Byung‐Chul Lee | Jong S. Kim | M. Mahagne | J. Labreuche | E. Meseguer | P. Lavallée | Hugo Charles | Maurice Giroud | Philippa C. Lavallée
[1] Hong Wang,et al. Stroke Prevention With the PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) Inhibitor Evolocumab Added to Statin in High-Risk Patients With Stable Atherosclerosis , 2020, Stroke.
[2] E. Vicaut,et al. A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke. , 2019, The New England journal of medicine.
[3] Deepak L. Bhatt,et al. Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES , 2019, Circulation.
[4] Xueli Yang,et al. Association of Lipids With Ischemic and Hemorrhagic Stroke: A Prospective Cohort Study Among 267 500 Chinese. , 2019, Stroke.
[5] E. Vicaut,et al. Treat stroke to target trial design: First trial comparing two LDL targets in patients with atherothrombotic strokes , 2019, European stroke journal.
[6] Peter Sandercock,et al. Interpretation of the evidence for the efficacy and safety of statin therapy , 2016, The Lancet.
[7] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.
[8] P. Amarenco,et al. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention , 2009, The Lancet Neurology.
[9] M. Hennerici,et al. Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial , 2008, Stroke.
[10] M. Hennerici,et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study , 2008, Neurology.
[11] Gary A. Ford,et al. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. , 2008, Cerebrovascular diseases.
[12] J. Farmer. High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.
[13] 曲东锋. Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .
[14] R. Collins,et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions , 2004, The Lancet.
[15] H. Koennecke. Secondary Prevention of Stroke , 2004, CNS drugs.
[16] M. Bojar. DEPARTMENT OF NEUROLOGY , 1923 .